Amidantel is an anti-parasitic drug that has been studied for its potential to treat various parasitic infections, particularly in animals. Its synthesis involves several steps, including the reaction of 2-amino-4,5-dimethylthiazole with 1,3-dichloro-2-propanol. Amidantel is known to exhibit anthelmintic activity, meaning it can kill or paralyze parasitic worms. Research on amidantel focuses on its efficacy against various parasitic infections, its potential for development as a veterinary drug, and its safety profile. However, there are limited clinical trials on humans, and its use in humans is not widely established.'
amidantel: RN given refers to parent cpd; structure
ID Source | ID |
---|---|
PubMed CID | 39521 |
CHEMBL ID | 2105966 |
CHEMBL ID | 4784193 |
SCHEMBL ID | 381858 |
MeSH ID | M0071369 |
Synonym |
---|
amidantel |
n-[4-[1-(dimethylamino)ethylideneamino]phenyl]-2-methoxyacetamide |
CHEMBL2105966 |
c67is11n0o , |
bay d 8815 [hydrochloride] |
amidantelum |
amidantel [inn:ban] |
amidantelum [inn-latin] |
unii-c67is11n0o |
49745-00-8 |
acetamide, n-(4-((1-(dimethylamino)ethylidene)amino)phenyl)-2-methoxy- |
4'-((1-(dimethylamino)ethylidene)amino)-2-methoxyacetanilide |
bay d 8815 free base |
bay-d-8815 free base |
bay-d 8815 free base |
amidantel [inn] |
SCHEMBL381858 |
DTXSID70198009 |
Q27275235 |
n-(4-((1-(dimethylamino)ethylidene)amino)phenyl)-2-methoxyacetamide |
49745-00-8 (free base) |
amidantel free base |
n-(4-{[1-(dimethylamino)ethylidene]amino}phenyl)-2-methoxyacetamide |
DTXSID80866141 |
CHEMBL4784193 |
AKOS040750417 |
The Amidantel is a new anthelmintic from a new chemical class. It has an interesting anthel mintic spectrum.
Excerpt | Reference | Relevance |
---|---|---|
"Amidantel is a new anthelmintic from a new chemical class with an interesting anthelmintic spectrum. " | ( The efficacy of amidantel, a new anthelmintic, on hookworms and ascarids in dogs. Thomas, H, 1979) | 2.05 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (45.45) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (16.94) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (9.09%) | 5.53% |
Reviews | 1 (9.09%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (81.82%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |